kesonotide (KS-c2)
/ Filamon
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 26, 2025
ADVICE: Early Phase Study of Kesonotide in Participants With Solid Tumours
(clinicaltrials.gov)
- P1/2 | N=80 | Recruiting | Sponsor: Filamon LTD | Not yet recruiting ➔ Recruiting
Enrollment open • Brain Cancer • Breast Cancer • Genetic Disorders • Genito-urinary Cancer • Glioblastoma • Hormone Receptor Positive Breast Cancer • Lung Cancer • Oncology • Ovarian Cancer • Pancreatic Cancer • Prostate Cancer • Skin Cancer • Solid Tumor
September 05, 2025
ADVICE: Early Phase Study of Kesonotide in Participants With Solid Tumours
(clinicaltrials.gov)
- P1/2 | N=80 | Not yet recruiting | Sponsor: Filamon LTD | Initiation date: May 2025 ➔ Oct 2025
Trial initiation date • Brain Cancer • Breast Cancer • Genetic Disorders • Genito-urinary Cancer • Glioblastoma • Hormone Receptor Positive Breast Cancer • Lung Cancer • Oncology • Ovarian Cancer • Pancreatic Cancer • Prostate Cancer • Skin Cancer • Solid Tumor
1 to 2
Of
2
Go to page
1